TickerFacts.

Champions Oncology, Inc. (CSBR): Share Repurchases

Annual figures by period end, from SEC filings.

$0
Year ended 2025-04-30
$1.03M2011-04-30: $1.03M2012-04-30: $02022-04-30: $02023-04-30: $74.0K2024-04-30: $634.0K2025-04-30: $0$0
2011-04-30 Share Repurchases (USD) 2025-04-30
Period endedShare RepurchasesChange YoYSource filing
2025-04-30$0-100.0%2025-07-23, From 2024-05-01
2024-04-30$634.0K+756.8%2025-07-23, From 2023-05-01
2023-04-30$74.0Kn/a2024-07-19, From 2022-05-01
2022-04-30$0n/a2023-07-24, From 2021-05-01
No annual figure between 2012-04-30 and 2022-04-30.
2012-04-30$0-100.0%2012-07-18, From 2011-05-01
2011-04-30$1.03Mn/a2012-07-18, From 2010-05-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
Champions Oncology, Inc. (CSBR)2025-04-30$0-100.0%
Invivyd, Inc. (IVVD)2024-12-31$0-100.0%
C4 Therapeutics, Inc. (CCCC)2025-12-31$193.0K-0.5%
Pelthos Therapeutics Inc. (PTHS)2025-12-31$0-100.0%
ADMA Biologics, Inc. (ADMA)2025-12-31$31.94Mn/a
Repligen Corp (RGEN)2025-12-31$0n/a
Bio-Techne Corp (TECH)2026-06-30$41.67M-84.9%
Halozyme Therapeutics, Inc. (HALO)2025-12-31$342.37M+36.9%
Moderna, Inc. (MRNA)2025-12-31$2.00Mn/a

Compare CSBR, IVVD, CCCC, PTHS side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗